EYEVANCE PHARMACEUTICALS
Eyevance is a provider of ophthalmic products and therapies intended to address unmet medical needs. The company's products target areas such as the anterior segment, posterior segment and glaucoma ailments, providing patients with optimal vision and a better quality of life.
EYEVANCE PHARMACEUTICALS
Founded:
2017-01-01
Address:
Fort Worth, Texas, United States
Country:
United States
Website Url:
http://www.eyevance.com
Total Employee:
1+
Status:
Active
Contact:
(817) 677-6120
Total Funding:
30 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Google Google Cloud COVID-19 DMARC WP Engine DMARC Analyzer
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Lensabl
Lensabl offers an online prescription lens replacement service.
MediPrint Ophthalmics
MediPrint Ophthalmics is a clinical stage eye care pharmaceutical company.
Current Employees Featured
Founder
Official Site Inspections
http://www.eyevance.com
- Host name: 246.21.139.34.bc.googleusercontent.com
- IP address: 34.139.21.246
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Eyevance Pharmaceuticals"
Santen and U.S. Ophthalmic Company Eyevance ... - Santen …
Sep 17, 2020 Eyevance Pharmaceuticals LLC (a wholly-owned subsidiary of Eyevance), adding that “We are excited to become part of Santen’s U.S. organization, to work in collaboration to …See details»
Santen and US ophthalmology company, Eyevance, enter into …
Santen recently announced the acquisition of Eyevance, a US-based ophthalmology company, specialised in the development and commercialisation of topical ophthalmic products targeting …See details»
Eyevance Pharmaceuticals - Crunchbase Company Profile & Funding
Organization. Eyevance Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Eyevance is a provider of …See details»
Santen and U.S. Ophthalmic Company Eyevance Enter into Share …
Sep 16, 2020 Eyevance Holdings LLC is a limited liability company, and, before this transaction, had two wholly-owned subsidiaries, Eyevance Pharmaceuticals Holdings Inc. and its operating …See details»
Santen and U.S. Ophthalmic Company Eyevance Enter into Share …
Sep 17, 2020 OSAKA, Japan and FORT WORTH, Texas, Sept. 16, 2020 /PRNewswire/ -- Santen Pharmaceutical Co., Ltd. (hereinafter "Santen") and Eyevance Holdings LLC …See details»
Santen and US ophthalmic company Eyevance enter into share …
As Eyevance embarks on this new journey with Santen, we sincerely appreciate the Eyevance Team and its shareholders for their unwavering support and continuous pursuit of excellence.” …See details»
Santen and U.S. Ophthalmic Company Eyevance Enter into Share
Sep 16, 2020 Santen Pharmaceutical Co., Ltd. and Eyevance Holdings LLC announced that Santen Holdings U.S. Inc., a wholly-owned subsidiary of Santen, ... “We are excited to become …See details»
Santen and U.S. Ophthalmic Company Eyevance ... - Associated …
OSAKA, Japan and FORT WORTH, Texas, Sept. 16, 2020 /PRNewswire/ -- Santen Pharmaceutical Co., Ltd. (hereinafter "Santen") and Eyevance Holdings LLC announced that …See details»
Santen Acquires Eyevance Pharmaceutical - Eyewire+
Sep 17, 2020 Eyevance’s current commercialization strategy is supported by a national sales team exclusively targeting ophthalmologists, optometrists, and allergists throughout the U.S. …See details»
Santen Acquires Eyevance in $225M Deal | INVISIONMAG.COM
Sep 20, 2020 Osaka-based Santen has acquired Fort Worth, TX-based Eyevance, which develops topical ophthalmic products, for $225 million. ... “We are excited to become part of …See details»
Fort Worth Ophthalmic Biotech Eyevance Exits to Japanese Firm …
Sep 17, 2020 Fort Worth is getting another huge biotech success story: Eyevance Holdings LLC has entered into a shared purchase agreement with Osaka, Japan-based Santen …See details»
Santen Acquires Eyevance Pharmaceuticals | Paragon Ventures
As Eyevance embarks on this new journey with Santen, we sincerely appreciate the Eyevance Team and its shareholders for their unwavering support and continuous pursuit of excellence.” …See details»
Eyevance Pharmaceuticals | VentureRadar
Eyevance is focused on developing innovative and impactful therapies that address unmet ophthalmic needs. Our mission is to ensure optimal vision and better quality of life for all …See details»
Fort Worth biotech company Eyevance Pharmaceuticals acquired …
Sep 18, 2020 Launched in 2017, Eyevance has developed a line of products that treat inflammation, allergy and infection of the eye. In 2019, the company reported raising $30 …See details»
INDUSTRY INSIDER | Ophthalmology Management - PentaVision
Apr 1, 2019 I have listened closely to my customers and truly felt there was a significant opportunity within the ophthalmic space for a small, emerging pharmaceutical company like …See details»
Santen and U.S. Ophthalmic Company Eyevance Enter into Share
Sep 16, 2020 Eyevance Holdings LLC is a limited liability company, and, before this transaction, had two wholly-owned subsidiaries, Eyevance Pharmaceuticals Holdings Inc. and its operating …See details»
VIDEO: Santen acquisition of Eyevance means ‘endless ... - Healio
Oct 14, 2020 In this Healio Video Perspective, Jerry St. Peter, CEO and Director of Eyevance Pharmaceuticals, discusses the recent acquisition of Eyevance by Santen.See details»
Santen Gobbles Up US Ophthalmic Player for US$225 Million
Sep 18, 2020 Japanese ophthalmology powerhouse Santen Pharmaceutical has acquired US eye drug player Eyevance Pharmaceuticals Holdings for US$225 million, hoping the deal will …See details»
Eyevance Pharmaceuticals Acquires TOBRADEX® ST and …
Oct 16, 2019 Eyevance also acquired the global rights to NATACYN®, the first and only FDA-approved ocular antifungal, which is listed on The World Health Organization's (WHO) list of …See details»
Eyevance Pharmaceuticals Launches ZERVIATE™ in the United States
Mar 30, 2020 Eyevance Pharmaceuticals is a Fort Worth, Texas-based company committed to developing and commercializing innovative and impactful ophthalmic products that enable …See details»